Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
For permission requests, please contact NEJM Reprints at reprints@nejm.org To the Editor: Solomon et al. (Oct. 24 issue)1 found that among patients with heart failure and mildly reduced or preserved ejection fraction, finerenone resulted in a lower rate of a composite of total worsening heart failure events and death from cardiovascular causes than placebo, with a rate ratio of 0.84 (95% confidence interval [CI], 0.74 to 0.95).
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
